Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Ultraprecise Antigen 10-in-1 Pool Testing by Multiantibodies Transistor Assay
Journal of the American Chemical Society  (IF16.383),  Pub Date : 2021-11-18, DOI: 10.1021/jacs.1c08598
Changhao Dai, Mingquan Guo, Yanling Wu, Ban-Peng Cao, Xuejun Wang, Yungen Wu, Hua Kang, Derong Kong, Zhaoqin Zhu, Tianlei Ying, Yunqi Liu, Dacheng Wei

Effective screening of infectious diseases requires a fast, cheap, and population-scale testing. Antigen pool testing can increase the test rate and shorten the screening time, thus being a valuable approach for epidemic prevention and control. However, the overall percent agreement (OPA) with polymerase chain reaction (PCR) is one-half to three-quarters, hampering it from being a comprehensive method, especially pool testing, beyond the gold-standard PCR. Here, a multiantibodies transistor assay is developed for sensitive and highly precise antigen pool testing. The multiantibodies capture SARS-CoV-2 spike S1 proteins with different configurations, resulting in an antigen-binding affinity down to 0.34 fM. The limit of detection reaches 3.5 × 10–17 g mL–1SARS-CoV-2 spike S1 protein in artificial saliva, 4–5 orders of magnitude lower than existing transistor sensors. The testing of 60 nasopharyngeal swabs exhibits ∼100% OPA with PCR within an average diagnoses time of 38.9 s. Owing to its highly precise feature, a portable integrated platform is fabricated, which achieves 10-in-1 pooled screening for high testing throughput. This work solves the long-standing problem of antigen pool testing, enabling it to be a valuable tool in precise diagnoses and population-wide screening of COVID-19 or other epidemics in the future.